TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Stefan Vonhoff
Vice President CMC at NOXXON Pharma AG

Profile

Stefan Vonhoff, Ph.D. is VP Chemistry&Manufacturing at NOXXON Pharma AG, Berlin, Germany, a biotech company developing Spiegelmers – enantiomeric aptamers – for various therapeutic indications in the oncology area. Stefan joined NOXXON in 1999 to support supply chain establishment for this novel class of oligonucleotide therapeutics. Today, his main responsibility is to coordinate external manufacturing and QC/QP-release activities for starting materials, drug substance, parenteral drug product and clinical trial supply.

Stefan Vonhoff's Network

Agenda Sessions

  • Workshop Moderator’s Opening Remarks

    , 13:00
  • Formulation Development and Device Options for the Subcutaneous Injection of Spiegelmer Drug Product Solution

    , 15:45